Study to Evaluate Safety, Tolerability, and Efficacy of GS-0976 in Adults With Nonalcoholic Steatohepatitis
Completed · Phase 2 · Has a placebo group
Conditions studied: Nonalcoholic Steatohepatitis (NASH)
In brief
The primary objective of this study is to evaluate the safety and tolerability of firsocostat in adults with nonalcoholic steatohepatitis (NASH).
Key facts
- Study ID
- NCT02856555
- Run by
- Gilead Sciences
- People needed
- 127
- Starts
- 2016-08-08
- Expected to finish
- 2017-07-18
- Last updated by the study team
- 2020-07-24
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Study site — Coronado, California, United States
- Study site — Foster City, California, United States
- Study site — Los Angeles, California, United States
- Study site — Los Angeles, California, United States
- Study site — Rialto, California, United States
- Study site — San Diego, California, United States
- Study site — San Diego, California, United States
- Study site — San Francisco, California, United States
- Study site — San Francisco, California, United States
- Study site — Miami, Florida, United States
- Study site — Miami, Florida, United States
- Study site — Atlanta, Georgia, United States
- Study site — Chicago, Illinois, United States
- Study site — Indianapolis, Indiana, United States
- Study site — New Orleans, Louisiana, United States
- Study site — Boston, Massachusetts, United States
- Study site — Rochester, Minnesota, United States
- Study site — Kansas City, Missouri, United States
- Study site — New York, New York, United States
- Study site — Durham, North Carolina, United States
- Study site — Statesville, North Carolina, United States
- Study site — Philadelphia, Pennsylvania, United States
- Study site — Pittsburgh, Pennsylvania, United States
- Study site — Germantown, Tennessee, United States
- Study site — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.